Protokinetix, Inc. is a research and development stage biotechnology company, which engages in the scientific medical research of anti-aging glycoproteins. The company was founded on December 23, 1999 and is headquartered in St. Marys, WV.
Company profile
Ticker
PKTX
Exchange
Website
CEO
Clarence Edward Smith
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
RJV NETWORK INC
SEC CIK
IRS number
943355026
PKTX stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
20 Mar 24
D
$200.00 k in equity, sold $110.00 k, 1 investor
28 Dec 23
10-Q
2023 Q3
Quarterly report
18 Oct 23
D/A
$500.00 k in equity, sold $429.00 k, 8 investors
7 Sep 23
10-Q
2023 Q2
Quarterly report
14 Jul 23
D/A
$400.00 k in equity, sold $364.00 k, 5 investors
16 Jun 23
D/A
$324.00 k in equity, sold $324.00 k, 5 investors
25 May 23
10-Q
2023 Q1
Quarterly report
2 May 23
10-K
2022 FY
Annual report
17 Mar 23
D/A
$250.00 k in equity, sold $149.00 k, 3 investors
7 Feb 23
Latest ownership filings
SC 13D/A
SMITH CLARENCE EDWARD
28 Dec 23
4
CLARENCE EDWARD SMITH
28 Dec 23
4
Michael Richard Guzzetta
27 Oct 23
4
CLARENCE EDWARD SMITH
30 Aug 23
SC 13D/A
SMITH CLARENCE EDWARD
15 Jun 23
4
CLARENCE EDWARD SMITH
15 Jun 23
4
CLARENCE EDWARD SMITH
24 May 23
SC 13G/A
Young Lachlan Grant
15 Feb 23
SC 13G/A
Smith Alexandra Blake
15 Feb 23
SC 13D/A
SMITH CLARENCE EDWARD
15 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 12.40 k | 12.40 k | 12.40 k | 12.40 k | 12.40 k | 12.40 k |
Cash burn (monthly) | 2.09 k | 2.61 k | 26.80 k | 73.89 k | 23.30 k | 37.14 k |
Cash used (since last report) | 12.48 k | 15.61 k | 160.27 k | 441.92 k | 139.35 k | 222.13 k |
Cash remaining | -82.04 | -3.21 k | -147.87 k | -429.52 k | -126.96 k | -209.74 k |
Runway (months of cash) | -0.0 | -1.2 | -5.5 | -5.8 | -5.4 | -5.6 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Dec 23 | Smith Clarence Edward | Common Stock | Buy | Acquire P | No | No | 0.015 | 7,333,334 | 110.00 k | 58,547,777 |
26 Oct 23 | Guzzetta Michael Richard | Common Stock | Buy | Acquire P | No | No | 0 | 20,000 | 0.00 | 736,369 |
29 Aug 23 | Smith Clarence Edward | Common Stock | Buy | Acquire P | No | No | 0.02 | 1,500,000 | 30.00 k | 51,214,443 |
15 Jun 23 | Smith Clarence Edward | Common Stock | Buy | Acquire P | No | No | 0.02 | 2,000,000 | 40.00 k | 49,714,443 |
22 May 23 | Smith Clarence Edward | Common Stock | Buy | Acquire P | No | No | 0.02 | 3,750,000 | 75.00 k | 47,714,443 |